ICD-10-CM Billable Code

F19.931

Other psychoactive substance use, unspecified with withdrawal delirium

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code F19.931 pertains to a condition characterized by the use of various psychoactive substances, which is not specified but includes cases involving withdrawal delirium. This condition occurs when an individual who has been using certain substances experiences a severe and sometimes life-threatening state during withdrawal. This article aims to provide a comprehensive overview of this condition, including its causes, symptoms, diagnosis, and general approaches to management.

Causes & Symptoms

Clinical Causes: Chronic or long-term use of psychoactive substances such as alcohol, sedatives, hypnotics, opiates, stimulants, or hallucinogens. Sudden discontinuation or reduction in substance intake after prolonged use. Inadequate medical supervision during withdrawal. Coexisting medical or psychiatric conditions that complicate the withdrawal process.

Key Symptoms: Altered mental status, including confusion and disorientation. Hallucinations, typically visual or auditory. Sensory disturbances like hypersensitivity to light, sound, or touch. Restlessness and agitation. Rapid heartbeat, sweating, and high blood pressure. Fluctuating levels of consciousness, potentially leading to coma. Delusional beliefs or paranoia.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a thorough clinical evaluation by a healthcare professional, focusing on the patient's medical history and recent substance use. Key tools include the patient's self-reported history, physical examination, and possibly laboratory tests to identify substances and rule out other causes of neurological symptoms. Mental health assessments may help determine the severity of symptoms and distinguish withdrawal delirium from other psychiatric conditions. Recognition of withdrawal symptoms in the context of recent cessation or reduction of psychoactive substances is critical for diagnosis.

Treatment Protocols: Management of withdrawal delirium typically requires hospitalization, especially if symptoms are severe. Treatment strategies include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F19.931 a billable ICD-10 code?
Yes, F19.931 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F19.931?
Clinical documentation must specify the nature of Other psychoactive substance use, unspecified with withdrawal delirium and any associated comorbidities for accurate reporting.

Cite this Clinical Reference